Through a global proteomics analysis, the study identifies human epidermal growth factor receptor 2 as a crucial target of FAM83A. Mechanistically, FAM83A facilitated ErbB2 expression at the posttranslational modification level via the E3 ubiquitin ligase STUB1.
[Cell Death & Disease]